Back to the main directory
Press Release
- Apogee Therapeutics to Participate in Upcoming August Investor Conferences by GlobeNewsWire
- Holley Introduces New Revolutionary Electronic Fuel Ignition System With Sniper 2 by BusinessWire
- InterRent REIT Reports 15% Same Property NOI Growth and Accelerated NOI Margin Expansion in Q2 2023 by BusinessWire
- Zevra Therapeutics to Report Second Quarter 2023 Results on August 14, 2023 by GlobeNewsWire
- Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- EQS-News: First Berlin Equity Research veröffentlicht die erste Coverage der bioXXmed AG mit Kaufempfehlung by EQS Group AG
- Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance by GlobeNewsWire
- NICE Named as a Top Provider by Constellation ShortList™ for Contact Center as a Service 2023 by BusinessWire
- LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference by GlobeNewsWire
- Recce Pharmaceuticals Receives Second Canadian Scientific Research and Experimental Development Rebate by GlobeNewsWire
- Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare Conference by GlobeNewsWire
- Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9 by GlobeNewsWire
- Biora Therapeutics to Participate in Canaccord Genuity 43rd Annual Growth Conference by GlobeNewsWire
- Freshworks to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Kala Pharmaceuticals Announces Name Change to KALA BIO by GlobeNewsWire
- AFCEA’s TechNet Augusta 2023 Taps EdgeTI to Present Digital Twins Data Mesh Solution by GlobeNewsWire
- TransUnion Research Finds Outdated Contact Data Negatively Impacts Customer Contactability, While Increasing Susceptibility to Compliance And Other Risks by GlobeNewsWire
- Pacira BioSciences Reports Second Quarter 2023 Financial Results by GlobeNewsWire
- Akari Therapeutics Announces the Appointment of Beth-Anne Lang as Senior Vice President, Regulatory Affairs by GlobeNewsWire
- ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time by GlobeNewsWire
- Stryve Foods, Inc. Regains Full Compliance with NASDAQ Listing Standards by GlobeNewsWire
- Jupiter Wellness, Inc. Announces Payment Date for the Distribution of Common Stock of SRM Entertainment, Inc. by GlobeNewsWire
- Jasper Therapeutics Strengthens Management Team with Key Appointments by GlobeNewsWire
- Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO) by GlobeNewsWire